Thomas Thomas T. - 14 Jun 2022 Form 4 Insider Report for OPIANT PHARMACEUTICALS, INC.

Role: Director
Signature: /s/ Thomas T. Thomas
Issuer symbol: N/A
Transactions as of: 14 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 14 Jun 2022, 16:49:17 UTC
Previous filing: 23 Sep 2021
Next filing: 03 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OPNT	Common Stock	Award	$0	+2,000	+19%	$0.000000	12,375	14 Jun 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date.

Content

2,000 shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date.